Brokerages forecast that Galena Biopharma, Inc. (NYSE:SLS) will post earnings per share (EPS) of ($0.27) for the current quarter, Zacks reports. Zero analysts have made estimates for Galena Biopharma’s earnings. Galena Biopharma reported earnings per share of ($1.47) during the same quarter last year, which would suggest a positive year-over-year growth rate of 81.6%. The company is scheduled to announce its next earnings report on Tuesday, May 21st.
On average, analysts expect that Galena Biopharma will report full year earnings of ($0.83) per share for the current financial year. For the next fiscal year, analysts forecast that the company will post earnings of ($0.97) per share. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Galena Biopharma.
Shares of SLS traded down $0.01 during trading hours on Monday, reaching $1.03. 249,100 shares of the stock traded hands, compared to its average volume of 332,076. Galena Biopharma has a 52 week low of $0.80 and a 52 week high of $6.97.
Galena Biopharma Company Profile
Featured Story: How do candlesticks reflect price movement?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Galena Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galena Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.